
Coloplast A/S
CLPBY | OTC
$6.47
+$0.02 (+0.31%)
At close: Sep 21, 2026, 3:59 PM ET
$6.47
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:00 PM ET
Fiscal Quarter Period Ending | Q3 2026 Jun 29, 2026 | Q2 2026 Mar 30, 2026 | Q1 2026 Dec 30, 2025 | Q4 2025 Sep 29, 2025 | Q3 2025 Jun 29, 2025 | Q2 2025 Mar 30, 2025 | Q1 2025 Dec 30, 2024 | Q4 2024 Sep 29, 2024 | Q3 2024 Jun 29, 2024 | Q2 2024 Mar 30, 2024 | Q1 2024 Dec 30, 2023 | Q4 2023 Sep 29, 2023 | Q3 2023 Jun 29, 2023 | Q2 2023 Mar 30, 2023 | Q1 2023 Dec 30, 2022 | Q4 2022 Sep 29, 2022 | Q3 2022 Jun 29, 2022 | Q2 2022 Mar 30, 2022 | Q1 2022 Dec 30, 2021 | Q4 2021 Sep 29, 2021 | Q3 2021 Jun 29, 2021 | Q2 2021 Mar 30, 2021 | Q1 2021 Dec 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 7.48B | 7.2B | 7.04B | 5.34B | 6.96B | 6.93B | 7.03B | 6.95B | 6.89B | 6.59B | 6.61B | 6.23B | 6.11B | 6.06B | 6.11B | 6.06B | 5.85B | 5.5B | 5.17B | 5.1B | 4.84B | 4.75B | 4.74B |
Cost of Revenue | 2.49B | 4.11B | 2.29B | 2.19B | 2.25B | 2.2B | 2.28B | 2.31B | 2.24B | 2.11B | 2.1B | 2.09B | 2.09B | 2.03B | 1.96B | 1.89B | 1.8B | 1.72B | 1.64B | 1.58B | 1.5B | 1.5B | 1.53B |
Gross Profit | 4.99B | 3.09B | 4.69B | 4.75B | 4.71B | 4.73B | 4.75B | 4.64B | 4.65B | 4.48B | 4.5B | 4.13B | 4.02B | 4.03B | 4.15B | 4.17B | 4.05B | 3.78B | 3.53B | 3.52B | 3.34B | 3.25B | 3.21B |
Operating Income | 1.94B | 1.83B | 1.85B | 1.91B | 1.83B | 1.89B | 1.91B | 1.91B | 1.86B | 1.79B | 1.82B | 1.65B | 1.71B | 1.65B | 1.76B | 1.78B | 1.74B | 1.31B | 1.62B | 1.85B | 1.59B | 1.38B | 1.54B |
Interest Income | 22.38M | 21.35M | 32M | 21.93M | 3.49M | 705.41K | 52M | 28M | 34M | 36M | 22M | 29M | 37M | 42M | 1M | 5M | 79M | 50M | 2M | 3M | 44M | 98M | 2M |
Pretax Income | 1.91B | -1.26B | 1.79B | 1.2B | 1.34B | 1.49B | 1.77B | 1.6B | 1.63B | 1.61B | 1.55B | 1.53B | 1.61B | 1.46B | 1.43B | 1.61B | 1.67B | 1.29B | 1.56B | 1.64B | 1.62B | 1.48B | 1.5B |
Net Income | 1.49B | -987.14M | 1.38B | 872.04M | 805M | 912M | 1.04B | 1.31B | 1.27B | 1.25B | 1.21B | 1.23B | 1.27B | 1.16B | 1.13B | 1.23B | 1.29B | 980M | 1.21B | 1.31B | 1.25B | 1.13B | 1.14B |
Selling & General & Admin | 2.77B | 2.67B | 2.64B | 2.59B | 2.58B | 2.63B | 2.62B | 2.58B | 2.55B | 2.48B | 2.47B | 2.18B | 2.13B | 2.16B | 2.16B | 2.15B | 2.08B | 1.88B | 1.69B | 1.67B | 1.59B | 1.5B | 1.5B |
Research & Development | 285.84M | 258.22M | 244.79M | 248.16M | 239M | 239M | 219M | 219M | 240M | 221M | 233M | 231M | 216M | 209M | 216M | 217M | 222M | 222M | 205M | 207M | 185M | 177M | 186M |
Other Expenses | 6.54 | -1.66B | -23.69M | -158K | 56M | -28M | -5M | -63M | 23M | -11M | -5M | -20M | -6M | -12M | -6M | -9M | -18M | -11M | -11M | -3M | -27M | -3M | -11M |
Operating Expenses | 3.06B | 1.27B | 2.87B | 2.83B | 2.87B | 2.84B | 2.84B | 2.73B | 2.79B | 2.69B | 2.68B | 2.42B | 2.34B | 2.36B | 2.37B | 2.36B | 2.29B | 2.1B | 1.88B | 1.87B | 1.74B | 1.67B | 1.67B |
Interest Expense | 196.33M | 137.24M | 164M | 183.38M | 490M | 316M | 204M | 219M | 237M | 201M | 174M | 187M | 141M | 232M | 122M | 92M | 149M | 68M | 6M | 6M | 17M | n/a | 7M |
Selling & Marketing Expenses | n/a | 2.35B | 2.32B | n/a | 2.24B | 2.33B | 2.33B | 2.29B | 2.25B | 2.15B | 2.13B | 1.91B | 1.87B | 1.88B | 1.87B | 1.87B | 1.81B | 1.62B | 1.49B | 1.45B | 1.4B | 1.33B | 1.31B |
Cost & Expenses | 5.54B | 5.37B | 5.19B | 3.84B | 5.13B | 5.04B | 5.11B | 5.05B | 5.03B | 4.81B | 4.78B | 4.51B | 4.42B | 4.39B | 4.33B | 4.25B | 4.09B | 3.82B | 3.52B | 3.45B | 3.24B | 3.18B | 3.2B |
Income Tax Expense | 419.1M | -277.54M | 394M | -9.34B | 537M | 579M | 725M | 289M | 357M | 355M | 342M | 298M | 338M | 306M | 300M | 382M | 382M | 307M | 350M | 339M | 365M | 345M | 359M |
Shares Outstanding (Basic) | 2.25B | 2.25B | 2.25B | 2.25B | 2.25B | 2.25B | 2.25B | 2.25B | 2.25B | 2.25B | 2.19B | 2.18B | 2.12B | 2.12B | 2.12B | 2.12B | 2.12B | 2.13B | 2.13B | 2.13B | 2.13B | 2.13B | 2.13B |
Shares Outstanding (Diluted) | 2.25B | 2.25B | 2.25B | 2.25B | 2.25B | 2.25B | 2.25B | 2.25B | 2.25B | 2.25B | 2.19B | 2.25B | 2.13B | 2.12B | 2.12B | 2.13B | 2.13B | 2.13B | 2.13B | 2.13B | 2.13B | 2.13B | 2.13B |
EPS (Basic) | 0.65 | -0.44 | 0.61 | 0.39 | 0.36 | 0.41 | 0.46 | 0.58 | 0.57 | 0.56 | 0.55 | 0.56 | 0.60 | 0.54 | 0.53 | 0.58 | 0.61 | 0.46 | 0.57 | 0.61 | 0.59 | 0.53 | 0.53 |
EPS (Diluted) | 0.65 | -0.44 | 0.61 | 0.39 | 0.36 | 0.41 | 0.46 | 0.58 | 0.57 | 0.56 | 0.55 | 0.55 | 0.60 | 0.54 | 0.53 | 0.58 | 0.61 | 0.46 | 0.57 | 0.61 | 0.59 | 0.53 | 0.53 |
EBITDA | 2.31B | 5.23B | 2.3B | 2.17B | 2.18B | 2.15B | 2.3B | 2.13B | 2.2B | 2.13B | 2.04B | 1.99B | 2.01B | 1.94B | 2.04B | 1.96B | 2.08B | 1.59B | 1.74B | 1.85B | 1.85B | 1.77B | 1.7B |
EBIT | 1.94B | 1.83B | 1.96B | 1.73B | 1.83B | 1.81B | 1.97B | 1.8B | 1.87B | 1.81B | 1.73B | 1.71B | 1.75B | 1.69B | 1.55B | 1.7B | 1.82B | 1.36B | 1.56B | 1.65B | 1.64B | 1.58B | 1.5B |
Depreciation & Amortization | 369.26M | 3.4B | 341.91M | 436.52M | 343M | 344M | 328M | 335M | 328M | 319M | 308M | 277M | 263M | 268M | 261M | 259M | 260M | 236M | 175M | 191M | 209M | 190M | 202M |
Add to Watchlist
Select watchlists to add or remove CLPBY